These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21572332)

  • 61. Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients.
    Wei J; Han B; Mao XY; Wei MJ; Yao F; Jin F
    Tumour Biol; 2012 Apr; 33(2):413-20. PubMed ID: 21922275
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.
    Wang T; McCullough LE; White AJ; Bradshaw PT; Xu X; Cho YH; Terry MB; Teitelbaum SL; Neugut AI; Santella RM; Chen J; Gammon MD
    Cancer; 2019 Nov; 125(21):3836-3844. PubMed ID: 31402456
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PTEN Genetic and Epigenetic Alterations Define Distinct Subgroups in North Indian Breast Cancer Patients.
    Kazim Z; Wahabi K; Perwez A; Lal P; Rizvi MA
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):269-276. PubMed ID: 30678449
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Basal-like breast cancer displays distinct patterns of promoter methylation.
    Lee JS; Fackler MJ; Lee JH; Choi C; Park MH; Yoon JH; Zhang Z; Sukumar S
    Cancer Biol Ther; 2010 Jun; 9(12):1017-24. PubMed ID: 20505321
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women.
    Zhao L; Yu Z; Li Y; Wen X; Ma W; Wang L; Ren J; Liu C; He M; Bai X; Sun M; Zheng Z; Mi X; Wang E; Olopade OI; Jin F; Wei M
    Med Oncol; 2012 Sep; 29(3):1569-75. PubMed ID: 22105146
    [TBL] [Abstract][Full Text] [Related]  

  • 66. BRCA1 in cancer, cell cycle and genomic stability.
    Jhanwar-Uniyal M
    Front Biosci; 2003 Sep; 8():s1107-17. PubMed ID: 12957814
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extent of breast cancer type 1 promoter methylation correlates with clinicopathological features in breast cancers.
    Sun MY; Chang XZ; Xu GY; Dong Y; Zhou ZJ; Liu T; Wang CQ; Li YS
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S354-S361. PubMed ID: 29970689
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ABERRANT METHYLATION OF CANCER-RELATED GENES IN VIETNAMESE BREAST CANCER PATIENTS: ASSOCIATIONS WITH CLINICOPATHOLOGICAL FEATURES.
    Dieu Vuong L; Ngoc Nguyen Q
    Exp Oncol; 2023 Oct; 45(2):195-202. PubMed ID: 37824772
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women.
    Jing MX; Mao XY; Li C; Wei J; Liu C; Jin F
    Tumour Biol; 2011 Aug; 32(4):713-9. PubMed ID: 21625942
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TIMP3 Promoter Methylation Represents an Epigenetic Marker of BRCA1ness Breast Cancer Tumours.
    Maleva Kostovska I; Jakimovska M; Popovska-Jankovic K; Kubelka-Sabit K; Karagjozov M; Plaseska-Karanfilska D
    Pathol Oncol Res; 2018 Oct; 24(4):937-940. PubMed ID: 29524167
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DNA co-methylation analysis suggests novel functional associations between gene pairs in breast cancer samples.
    Akulenko R; Helms V
    Hum Mol Genet; 2013 Aug; 22(15):3016-22. PubMed ID: 23571108
    [TBL] [Abstract][Full Text] [Related]  

  • 72. BRCA1 methylation in breast duct carcinoma, a practical study in Duhok-Iraq.
    Hasan NA; Pity IS
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):34-39. PubMed ID: 38279496
    [TBL] [Abstract][Full Text] [Related]  

  • 73. BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers.
    Niwa Y; Oyama T; Nakajima T
    Jpn J Cancer Res; 2000 May; 91(5):519-26. PubMed ID: 10835497
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter.
    Lu Y; Chu A; Turker MS; Glazer PM
    Mol Cell Biol; 2011 Aug; 31(16):3339-50. PubMed ID: 21670155
    [TBL] [Abstract][Full Text] [Related]  

  • 75. BRCA1 methylation: a significant role in tumour development?
    Catteau A; Morris JR
    Semin Cancer Biol; 2002 Oct; 12(5):359-371. PubMed ID: 12191635
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Promoter methylation of
    Guo T; Ren Y; Wang B; Huang Y; Jia S; Tang W; Luo Y
    Mol Clin Oncol; 2015 Nov; 3(6):1353-1360. PubMed ID: 26807247
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer.
    Lobanova O; Medvedieva N; Fishchuk L; Dubitska O; Cheshuk V; Vereshchako R; Zakhartseva L; Rossokha Z; Gorovenko N
    Breast Cancer Res Treat; 2022 Dec; 196(3):505-515. PubMed ID: 36284026
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Promoter methylation and expression changes of
    Li Q; Wei W; Jiang YI; Yang H; Liu J
    Oncol Lett; 2015 Apr; 9(4):1807-1813. PubMed ID: 25789047
    [No Abstract]   [Full Text] [Related]  

  • 79. Epigenetic repression of phosphatidylethanolamine N-methyltransferase (PEMT) in BRCA1-mutated breast cancer.
    Li D; Bi FF; Chen NN; Cao JM; Sun WP; Zhou YM; Cao C; Li CY; Yang Q
    Oncotarget; 2014 Mar; 5(5):1315-25. PubMed ID: 24675476
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies.
    Yang R; Stöcker S; Schott S; Heil J; Marme F; Cuk K; Chen B; Golatta M; Zhou Y; Sutter C; Wappenschmidt B; Schmutzler R; Bugert P; Qu B; Bartram CR; Sohn C; Schneeweiss A; Burwinkel B
    Carcinogenesis; 2017 Mar; 38(3):312-320. PubMed ID: 28426874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.